Literature DB >> 22660803

Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission: findings on renal biopsy.

Duvuru Geetha1, Philip Seo, Carla Ellis, Michael Kuperman, Stuart M Levine.   

Abstract

OBJECTIVE: Hematuria is considered a sign of active renal disease in patients with small-vessel vasculitis. In patients who are in apparent clinical remission, presence of persistent or new-onset microscopic hematuria may reflect active vasculitis, damage, or other glomerular pathology.
METHODS: We identified 74 patients from the Johns Hopkins Renal Pathology database between 1995 and 2009 with the diagnosis of pauciimmune glomerulonephritis (GN). Among them we identified 9 who were in clinical remission and underwent a renal biopsy for evaluation of persistent or new-onset hematuria.
RESULTS: Nine patients with small-vessel vasculitis, 8 antineutrophil cytoplasmic antibody (ANCA)-positive and 1 ANCA-negative, underwent a renal biopsy at variable time periods after remission of vasculitis (6 to 164 months) for persistent microscopic hematuria (n = 6) or new-onset microscopic hematuria (n = 3). All patients were in apparent clinical remission at the time of renal biopsy. Of the 3 patients presenting with new-onset hematuria, 2 had crescentic IgA nephropathy and 1 had healed crescentic pauciimmune GN. Of the 6 patients with persistent hematuria, 2 had arteriosclerosis, 2 had focal segmental glomerulosclerosis, and 2 had global and segmental glomerulosclerosis and healed crescentic GN, and none had active vasculitis.
CONCLUSION: Microscopic hematuria in patients with renal vasculitis otherwise in remission could represent chronic glomerular injury from prior episode of vasculitis or may represent new glomerular pathology. Renal biopsy should be considered in these patients to guide therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22660803     DOI: 10.3899/jrheum.111608

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Persistent Hematuria in ANCA Vasculitis: Ominous or Innocuous?

Authors:  Shannon L Mahoney; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-25       Impact factor: 8.237

Review 2.  Update on ANCA-associated vasculitis: from biomarkers to therapy.

Authors:  Martina Tedesco; Maurizio Gallieni; Francesca Pellegata; Mario Cozzolino; Federico Alberici
Journal:  J Nephrol       Date:  2019-07-12       Impact factor: 3.902

3.  Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies.

Authors:  Magdalena Mosakowska; Dorota Brodowska Kania; Katarzyna Szamotulska; Aleksandra Rymarz; Stanisław Niemczyk
Journal:  BMC Nephrol       Date:  2021-08-26       Impact factor: 2.388

4.  Predictors of poor prognosis in ANCA-associated vasculitis (AAV): a single-center prospective study of inpatients in China.

Authors:  Ronglin Gao; Zhenzhen Wu; Xianghuai Xu; Jincheng Pu; Shengnan Pan; Youwei Zhang; Shuqi Zhuang; Lufei Yang; Yuanyuan Liang; Jiamin Song; Jianping Tang; Xuan Wang
Journal:  Clin Exp Med       Date:  2022-10-16       Impact factor: 5.057

Review 5.  Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies.

Authors:  Adél Molnár; Péter Studinger; Nóra Ledó
Journal:  Front Med (Lausanne)       Date:  2022-06-03

6.  Hematuria duration does not predict kidney function at 1 year in ANCA-associated glomerulonephritis.

Authors:  Teresa K Chen; Christine Murakami; Rebecca L Manno; Duvuru Geetha
Journal:  Semin Arthritis Rheum       Date:  2014-03-28       Impact factor: 5.532

7.  The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.

Authors:  Rennie L Rhee; John C Davis; Linna Ding; Fernando C Fervenza; Gary S Hoffman; Cees G M Kallenberg; Carol A Langford; W Joseph McCune; Paul A Monach; Philip Seo; Robert Spiera; E William St Clair; Ulrich Specks; John H Stone; Peter A Merkel
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-25       Impact factor: 8.237

8.  Microscopic Haematuria and Clinical Outcomes in Patients With Stage 3-5 Nondiabetic Chronic Kidney Disease.

Authors:  Hugo You-Hsien Lin; Chun-Yu Yen; Lee-Moay Lim; Daw-Yang Hwang; Jer-Chia Tsai; Shang-Jyh Hwang; Chi-Chih Hung; Hung-Chun Chen
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

9.  Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria.

Authors:  Chihiro Iwasaki; Takahito Moriyama; Kayu Tanaka; Takashi Takei; Kosaku Nitta
Journal:  J Nephropathol       Date:  2016-02-25

10.  Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis.

Authors:  Joop P Aendekerk; Sjoerd A M E G Timmermans; Matthias H Busch; Judith Potjewijd; Peter Heeringa; Jan G M C Damoiseaux; Chris P Reutelingsperger; Pieter van Paassen
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-17       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.